Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2696 Results
PIK Professor Michael Platt Earns $2.9 Million NIH Award for Neural Circuitry Work

PIK Professor Michael Platt Earns $2.9 Million NIH Award for Neural Circuitry Work

Michael Platt of the University of Pennsylvania has received a five-year, $2.9 million Method to Extend Research In Time, or MERIT, award from the National Institute of Mental Health to continue his work on the neural circuits that mediate compl

Michele W. Berger

Quieting Cells' Low-Oxygen Alarm Stops Flare-ups in Rare Bone Disorder, Penn Animal Study Finds

Quieting Cells' Low-Oxygen Alarm Stops Flare-ups in Rare Bone Disorder, Penn Animal Study Finds

The cellular response to the lack of oxygen fans the flames of flare-ups in a rare bone disorder. In fibrodysplasia ossificans progressiva (FOP), a mutation triggers bone growth in muscles, which limits motion, breathing, and swallowing, among a host of progressive symptoms. 

Karen Kreeger

Penn/Vanderbilt Study: Genetic Risk Factors of Disparate Diseases Share Similar Biological Underpinnings

Penn/Vanderbilt Study: Genetic Risk Factors of Disparate Diseases Share Similar Biological Underpinnings

The discovery of shared biological properties among independent variants of DNA sequences offers the opportunity to broaden understanding of the biological basis of disease and identify new therapeutic targets, according to a collaboration between the Perelman School of Medicine at the University of Pennsylvania, the University of Arizona Health Sciences

Karen Kreeger

Penn Institute for Biomedical Informatics and colleagues Identify "Roadmap" of Disease Mechanisms to Identify Candidate Drug Targets

Penn Institute for Biomedical Informatics and colleagues Identify "Roadmap" of Disease Mechanisms to Identify Candidate Drug Targets

The discovery of shared biological properties among independent variants of DNA sequences offers the opportunity to broaden understanding of the biological basis of disease and identify new therapeutic targets, according to a collaboration between the Perelman School of Medicine at the University of Pennsyl

Karen Kreeger

Penn Study: A Long-noncoding RNA Regulates Repair of DNA Breaks in Triple-Negative Breast Cancer Cells

Penn Study: A Long-noncoding RNA Regulates Repair of DNA Breaks in Triple-Negative Breast Cancer Cells

The discovery of long non-coding RNA (lncRNA) has dramatically changed the understanding of the biology of diseases such as cancer. The human genome contains about 20,000 protein-coding genes – less than 2 percent of the total – but 70 percent of the genome is made into non-gene-encoding RNA.

Karen Kreeger

Penn Study: Medicare Patients Have Low Adherence to Biologic Drug Therapy for Psoriasis

Penn Study: Medicare Patients Have Low Adherence to Biologic Drug Therapy for Psoriasis

About half of Medicare patients who start taking biologic therapies for moderate to severe plaque psoriasis stop within a year, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Previous studie

Katie Delach

Penn Study Suggests Changes in Skin "Microbiome" During Canine Atopic Dermatitis Could Lead to Antibiotic-Free Therapies for Human and Canine Disease

Penn Study Suggests Changes in Skin "Microbiome" During Canine Atopic Dermatitis Could Lead to Antibiotic-Free Therapies for Human and Canine Disease

Atopic dermatitis (AD), a chronic inflammatory skin condition and the most common form of eczema, is estimated to afflict as much as 10 percent of the U.S. population, and is much more common now than it was 50 years ago. Veterinary clinical estimates also show that approximately 10 percent of dogs have atopic dermatitis.

Katie Delach

Penn Study: Medicare Patients Have Low Adherence to Biologic Drug Therapy for Psoriasis

Penn Study: Medicare Patients Have Low Adherence to Biologic Drug Therapy for Psoriasis

About half of Medicare patients who start taking biologic therapies for moderate to severe plaque psoriasis stop within a year, according to a study led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Previous studie

Katie Delach

Penn Medicine Study Uncovers New Pathways that Control Skin Tanning and Lightening

Penn Medicine Study Uncovers New Pathways that Control Skin Tanning and Lightening

When skin cells responsible for pigmentation are exposed to estrogen or progesterone, the cells respond by adjusting their melanin production, resulting in either skin darkening or lightening. Although pregnant women often experience alterations in skin pigmentation, the reason for the changes has long puzzled physicians.

Katie Delach